Cancer care often aims to boost immunity, while transplant care suppresses it. Women typically mount stronger immune responses, which may aid tumor control but threaten graft survival. This interactive session invites oncology and transplant experts to exchange evidence and practice: 1) Do women do better or worse than men across cancer and transplant contexts? 2) What should be different in transplant care for women? 3) How should we tailor cancer screening, hormonal therapy, and family‑building plans for female transplant candidates and recipients? Attendees will gain practical, consensus‑minded takeaways and clearly identified research gaps.

Goals and objectives: 1. Summarize current evidence on sex‑specific differences in cancer outcomes and transplant survival, highlighting areas of consensus vs. controversies. 2. Define practical considerations for women’s transplant care (drug pharmacokinetics, rejection risk, infection vs. cancer trade‑offs, pregnancy and menopause). 3. Propose actionable pathways to personalize screening, hormonal management, and reproductive planning for female transplant patients.